Choksi Laboratories Fair Value
Choksi Laboratories (CHOKSILA) average fair value is ₹92.42 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹198.05 (-53.33%), fair value range ₹37.14–₹214.93. Browse CHOKSILA cash flow statement for revenue, profit, balance sheet and cash flow data.
Fair Value Analysis Export
CHOKSILA Fair Value vs Current Price — Valuation Summary
CHOKSILA average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. For live price and a broader fundamental view, visit Choksi Laboratories screener.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
CHOKSILA Fair Value Analysis — Data Sources & Coverage
Choksi Laboratories financial data sources, valuation methods applied and sector benchmarks used. Read Choksi Laboratories dividend policy for the complete payout history and dividend yield track record.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
CHOKSILA vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Choksi Laboratories P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Apollo Hospitals | APOLLOHOSP | 57.92 | 13.27 | ₹128,608 |
| Dr. Agarwal's Health Care | AGARWALEYE | 86.82 | 7.91 | ₹15,914 |
| Broach Lifecare Hospital | BROACH | - | - | ₹9 |
| Gujarat Kidney and Super… | GKSL | 81.75 | 5.41 | ₹1,332 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.